Total planned funding: $326,584,598
Allocations
Countries/Regions
Eswatini | $326,584,598 |
Organizational Types
Private Contractor | $94,185,961 |
University | $54,880,095 |
Unknown | $53,889,218 |
NGO | $52,845,069 |
Own Agency | $37,702,648 |
FBO | $13,230,009 |
Multi-lateral Agency | $9,554,780 |
Host Country Government Agency | $8,644,478 |
Other USG Agency | $1,625,509 |
Implementing Agency | $26,831 |
Program Areas
Treatment | $100,254,316 |
Care | $95,230,497 |
Prevention | $59,168,107 |
Testing | $25,851,454 |
Governance and Systems | $24,933,358 |
Management and Operations | $21,146,866 |
Budget Codes
HTXS: Treatment: Adult Treatment | $77,771,362 |
HBHC: Care: Adult Care and Support | $40,763,206 |
HKID: Care: Orphans and Vulnerable Children | $35,275,453 |
HVCT: Testing: HIV Testing and Counseling | $25,851,454 |
HVOP: Sexual Prevention: Other Sexual Prevention | $25,142,649 |
HVMS: Management and Operations | $21,146,866 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $20,642,984 |
HTXD: Treatment: ARV Drugs | $16,300,696 |
HVTB: Care: TB/HIV | $11,960,778 |
OHSS: Health Systems Strengthening | $11,287,115 |
HVSI: Strategic Information | $9,902,313 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,815,901 |
PDCS: Care: Pediatric Care and Support | $7,231,060 |
PDTX: Treatment: Pediatric Treatment | $6,182,258 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,154,602 |
HLAB: Laboratory Infrastructure | $3,743,930 |
HMBL: Biomedical Prevention: Blood Safety | $411,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$44,556,412
Countries/Regions
Pact, Inc.:
$36,455,257
Countries/Regions
Not Available:
$35,579,352
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions